• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声介导硝酸益康唑经皮给药治疗雷诺现象的潜力。

Ultrasound-mediated topical delivery of econazole nitrate with potential for treating Raynaud's phenomenon.

机构信息

College of Pharmacy and Pharmaceutical Sciences, The University of Toledo Health Science Campus, The University of Toledo, Toledo, OH 43614, USA.

College of Pharmacy and Pharmaceutical Sciences, The University of Toledo Health Science Campus, The University of Toledo, Toledo, OH 43614, USA; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Ajman University, Ajman, United Arab Emirates.

出版信息

Int J Pharm. 2020 Apr 30;580:119229. doi: 10.1016/j.ijpharm.2020.119229. Epub 2020 Mar 14.

DOI:10.1016/j.ijpharm.2020.119229
PMID:32184178
Abstract

The study aims to assess the ultrasound-assisted econazole nitrate (EN) permeation from topically applied formulations with potential for treating Raynaud's phenomenon. Optimization of ultrasound parameters such as the distance of the horn, application time and amplitude were performed. In vitro percutaneous absorption studies were performed using econazole formulations (F2_HPMC dispersion, F4_Lipoderm® Activemax™ Cream) across the ultrasound-treated porcine skin and were compared with the control group (skin samples without ultrasound). Histology and ATR-FTIR studies were performed on treated skin samples. A constant frequency (20 kHz) ultrasound application with 40% amplitude, 0.5 cm distance between ultrasound horn and the skin surface for 2 min was optimized. The permeation of EN was found to be higher from ultrasound-treated skin samples than the control group. Drug permeation from F2_HPMC dispersion was found to be higher as compared to the other formulations and the marketed EN cream. Histological evaluation confirmed that F2_HPMC dispersion showed no signs of toxicity. ATR-FTIR studies revealed a slight increase in the CH stretching vibrations (~2920 cm and 2850 cm) in ultrasound-treated skin samples as compared with the control. In conclusion, the ultrasound-assisted transdermal delivery of F2_HPMC dispersion could be further studied as a new therapy for Raynaud's phenomenon.

摘要

本研究旨在评估硝酸益康唑(EN)经皮透过应用制剂的超声辅助传递,这些制剂具有治疗雷诺现象的潜力。对超声参数(如喇叭距离、应用时间和振幅)进行了优化。采用超声处理的猪皮进行了体外经皮吸收研究,比较了超声处理组和对照组(未超声处理的皮肤样本)的经皮吸收情况。对处理后的皮肤样本进行了组织学和 ATR-FTIR 研究。优化后的超声参数为:固定频率(20 kHz),40%的振幅,超声喇叭与皮肤表面的距离为 0.5 cm,作用时间为 2 分钟。研究发现,与对照组相比,经超声处理的皮肤样本中 EN 的渗透量更高。与其他制剂和市售的 EN 乳膏相比,F2_HPMC 分散体的药物渗透量更高。组织学评估证实 F2_HPMC 分散体没有毒性迹象。ATR-FTIR 研究显示,与对照组相比,超声处理后的皮肤样本中的 CH 伸缩振动略有增加(~2920 cm 和 2850 cm)。总之,F2_HPMC 分散体的超声辅助经皮传递可进一步作为治疗雷诺现象的新疗法进行研究。

相似文献

1
Ultrasound-mediated topical delivery of econazole nitrate with potential for treating Raynaud's phenomenon.超声介导硝酸益康唑经皮给药治疗雷诺现象的潜力。
Int J Pharm. 2020 Apr 30;580:119229. doi: 10.1016/j.ijpharm.2020.119229. Epub 2020 Mar 14.
2
Evaluation of topical econazole nitrate formulations with potential for treating Raynaud's phenomenon.评价具有治疗雷诺现象潜力的硝酸益康唑局部制剂。
Pharm Dev Technol. 2019 Jul;24(6):689-699. doi: 10.1080/10837450.2019.1578371. Epub 2019 Apr 26.
3
Transethosomes of Econazole Nitrate for Transdermal Delivery: Development, In-vitro Characterization, and Ex-vivo Assessment.用于透皮给药的硝酸益康唑传递体:研制、体外特性及离体评估
Pharm Nanotechnol. 2018;6(3):171-179. doi: 10.2174/2211738506666180813122102.
4
Percutaneous delivery of econazole using microemulsion as vehicle: formulation, evaluation and vesicle-skin interaction.经皮递送酮康唑微乳作为载体:制剂、评价及囊泡-皮肤相互作用。
Int J Pharm. 2014 Apr 25;465(1-2):120-31. doi: 10.1016/j.ijpharm.2014.02.012. Epub 2014 Feb 12.
5
Evaluation of solid lipid microparticles produced by spray congealing for topical application of econazole nitrate.喷雾冷凝法制备的用于硝酸益康唑局部给药的固体脂质微粒的评价
J Pharm Pharmacol. 2009 May;61(5):559-67. doi: 10.1211/jpp/61.05.0003.
6
Bioequivalence Methodologies for Topical Drug Products: In Vitro and Ex Vivo Studies with a Corticosteroid and an Anti-Fungal Drug.局部用药品的生物等效性方法:皮质类固醇和抗真菌药物的体外和离体研究
Pharm Res. 2017 Apr;34(4):730-737. doi: 10.1007/s11095-017-2099-1. Epub 2017 Jan 17.
7
Near infrared spectrometry for the quantification of human dermal absorption of econazole nitrate and estradiol.用于定量测定硝酸益康唑和雌二醇经皮吸收的近红外光谱法。
Pharm Res. 2007 Jan;24(1):186-93. doi: 10.1007/s11095-006-9140-0. Epub 2006 Nov 14.
8
Novel drug delivery strategies for improving econazole antifungal action.新型药物递送策略提高克霉唑抗真菌作用。
Int J Pharm. 2015 Nov 10;495(1):599-607. doi: 10.1016/j.ijpharm.2015.09.015. Epub 2015 Sep 14.
9
Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies.固体脂质纳米粒作为硝酸益康唑局部给药的载体:体外表征、离体和体内研究
J Pharm Pharmacol. 2007 Aug;59(8):1057-64. doi: 10.1211/jpp.59.8.0002.
10
Development of thermodynamically stable nanostructured lipid carrier system using central composite design for zero order permeation of econazole nitrate through epidermis.采用中心复合设计研制热力学稳定的纳米结构脂质载体系统,以实现硝酸益康唑零级经皮渗透。
Pharm Dev Technol. 2013 May-Jun;18(3):634-44. doi: 10.3109/10837450.2012.659256. Epub 2012 Feb 18.

引用本文的文献

1
Intelligent transdermal nanoparticles as synergizing advanced delivery systems for precision therapeutics.智能透皮纳米颗粒作为用于精准治疗的协同先进递送系统。
Mater Today Bio. 2025 Aug 22;34:102220. doi: 10.1016/j.mtbio.2025.102220. eCollection 2025 Oct.
2
Simultaneous Delivery of Econazole, Terbinafine and Amorolfine with Improved Cutaneous Bioavailability: A Novel Micelle-Based Antifungal "Tri-Therapy".同时递送益康唑、特比萘芬和阿莫罗芬并提高皮肤生物利用度:一种新型的基于胶束的抗真菌“三联疗法”。
Pharmaceutics. 2022 Jan 24;14(2):271. doi: 10.3390/pharmaceutics14020271.
3
Roles of Lipids in the Permeability Barriers of Skin and Oral Mucosa.
脂质在皮肤和口腔黏膜渗透屏障中的作用。
Int J Mol Sci. 2021 May 15;22(10):5229. doi: 10.3390/ijms22105229.
4
Physical Enhancement? Nanocarrier? Current Progress in Transdermal Drug Delivery.物理增强?纳米载体?经皮给药的当前进展。
Nanomaterials (Basel). 2021 Jan 28;11(2):335. doi: 10.3390/nano11020335.